A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to ...

Scientists have identified a mirror-image form of the amino acid cysteine that selectively slows the growth of certain cancers while leaving healthy cells largely unharmed. Credit: Shutterstock ...

Hoover Institution senior fellow Victor Davis Hanson offered a rare direct update on his health Monday following lung cancer surgery. In December, Hanson, 72, a famed author, scholar and conservative ...

Scientists in Korea have uncovered evidence that a common and aggressive brain tumor in young adults may begin developing years before it becomes visible on medical scans. By identifying hidden mutant ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...

Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic tangles overwhelm normal repair pathways, cells flip on a fast but error-prone ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...

In the hour-long special “Killing Cancer: The Power Within,” NewsNation examines Dr. Patrick Soon-Shiong’s new immunotherapy cancer treatment, Anktiva, which he says could have the potential to ...

Researchers from UC San Digo have discovered an unusual new way by which cancer cells, illustrated here, can resist treatment and regrow. Photo credit: iStock/wildpixel The emergence of cancer drug ...

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug recognizes a unique fold in the RNA and triggers the cell to destroy it.

A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found. A colorized three dimensional micrographic scan of a melanoma cell. Recent ...